One of the major factors for the growth of the market of PCD (Primary Ciliary Dyskinesia) has been the increasing prevalence of respiratory tract diseases. According to the Centers for disease control and prevention, 9.3 million adults are diagnosed with respiratory problems, whereas 147,101 deaths occurred due to chronic lower
respiratory diseases. Thus owing to more number of developing nations present in the region, Asia Pacific will be the fastest growing market with a rising population getting various respiratory diseases.
“Medicine is not only a science; it is also an art. It does not consist of compounding pills and plasters; it deals with the very processes of life, which must be understood before they may be guided,” said Paracelsus, a Swiss physician who developed a new approach to medicine and philosophy based on observation and experience.
Also if we look at the report from the World Health Organization (WHO), over seven million deaths occur each year, wherein more than six million deaths result from direct use of tobacco.
While, lack of awareness about rare respiratory diseases, and high cost of the current treatment methods has been some of the major hurdles that players in the market needs to overcome to contribute to the market’s growth bandwagon, according to the report.
PCD Market Segmentation
There are numerous sides to the primary ciliary dyskinesia market, when we talk about it from the basis of diagnosis, the market is segmented into electron microscopy, genetic testing among others. Furthermore, the market is divided into drug treatment, radiotherapy, chemotherapy, to name a few, and is done on the basis of treatment. In addition, it is further segmented into erythromycin, clarithromycin, azithromycin, to name a few.
Today the market needs players who can offer a complete range of healthcare products across India and come with the capability to deal with products like antibiotics, anti-inflammatory, antacids, expectorants and antitussives, anti-allergic, ointments, among others. Therefore, increasing the distributor network and improvising products so as to meet the dynamic business needs is the need of the hour.
With rapid evolution in technology capabilities, PCD market must integrate and adopt latest technologies so as to stay relevant in offering quality products by maintaining robust safety and purity. This means the creation of a homestead of high-quality and affordable medicines that can be made available to everyone. As health is one such factor which no one can compromise on, PCD has become a critical segment that needs robust players to carry on the overall growth bandwagon of the industry itself by manufacturing, exporting and supplying a diverse array of Pharmaceutical Medicines.
